Phood

Nestlé buys Louisiana depression food firm

Nestlé buys Louisiana depression food firm

By Shane STARLING

Nestlé has bought its second brain health-focused medical foods start-up in eight months after snaffling Red River Pharma-owned Pamlab which makes high-dose vitamin supplements targeting depression, diabetes and Alzheimer’s.

GOED: Pharma is important for omega-3 but growing slowly

GOED: Pharma is important for omega-3 but growing slowly

By Shane Starling

Pharmaceutical omega-3 products are important but will grow more slowly than some expect because of the long timeframe for drug approval, says the chief of the Global Organisation for EPA and DHA Omega-3s (GOED).

How high can high-end omega-3 go?

Special edition: Omega-3 (Editor's blog)

How high can high-end omega-3 go?

By Shane STARLING

Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.

The year ahead: 2013 European nutra futures

The year ahead: 2013 European nutra futures

By Shane STARLING

The economic crisis has hit the EU hard, and coupled with a severe health and nutrition claim clamp down, the past years have been challenging for the European nutra industry.

Follow us

Featured Events

View more

Products

View more

Webinars